High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma

Journal of Thoracic Oncology

Volumn 10, Issue 4, 2015, Pages 565-576

  Nasu, Masaki ^a   Emi, Mitsuru ^a   Pastorino, Sandra ^a   Tanji, Mika ^a   Powers, Amy ^a   Luk, Hugh ^a   Baumann, Francine ^a   Zhang, Yu An ^b   Gazdar, Adi ^a,c   Kanodia, Shreya ^a   Tiirikainen, Maarit ^a   Flores, Erin ^a   Gaudino, Giovanni ^d   Becich, Michael J ^e   Pass, Harvey I ^a   Yang, Haining ^a   Carbone, Michele ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

BAP1; Malignant mesothelioma; multiplex ligation dependent probe amplification; Somatic BAP1 mutation; Sporadic malignant mesothelioma

Indexed keywords

BREAST CANCER 1 ASSOCIATED PROTEIN 1; COMPLEMENTARY DNA; DEUBIQUITINASE; RNA; UNCLASSIFIED DRUG; BAP1 PROTEIN, HUMAN; DNA; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE;

ARTICLE; DNA SEQUENCE; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LIVER BIOPSY; MALIGNANT MESOTHELIOMA; METHYLATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SOMATIC MUTATION; WILD TYPE; ADULT; AGED; BIOPSY; FEMALE; GENETICS; INCIDENCE; LUNG NEOPLASMS; MALE; MESOTHELIOMA; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; PLEURAL NEOPLASMS; PROGNOSIS; TUMOR CELL CULTURE; UNITED STATES; YOUNG ADULT;

ADULT; AGED; BIOPSY; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; MUTATION; NEW YORK; PLEURAL NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE; YOUNG ADULT;

EID: 84938286152     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000471     Document Type: Article

References (49)

1. Carbone M, Ly BH, Dodson RF, Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol 2012 227 44 58
2. Ismail-Khan R, Robinson LA, Williams CC Jr, Garrett CR, Bepler G, Simon GR, Malignant pleural mesothelioma: a comprehensive review. Cancer Control 2006 13 255 263
3. Baumann F, Ambrosi JP, Carbone M, Asbestos is not just asbestos: an unrecognised health hazard. Lancet Oncol 2013 14 576 578
4. Roushdy-Hammady I, Siegel J, Emri S, Testa JR, Carbone M, Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 2001 357 444 445
5. Testa JR, Cheung M, Pei J, Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 2011 43 1022 1025
6. Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G, BAP1 and cancer. Nat Rev Cancer 2013 13 153 159
7. Wiesner T, Obenauf AC, Murali R, Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 2011 43 1018 1021
8. Carbone M, Ferris LK, Baumann F, BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med 2012 10 179
9. Popova T, Hebert L, Jacquemin V, Germline BAP1 mutations predispose to renal cell carcinomas. Am J Hum Genet 2013 92 974 980
10. Jiao Y, Pawlik TM, Anders RA, Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet 2013 45 1470 1473
11. Wadt KA, Aoude LG, Johansson P, A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma. Clin Genet 2014. [Epub ahead of print
12. Misaghi S, Ottosen S, Izrael-Tomasevic A, Association of C-Terminal ubiquitin hydrolase BRCA1-Associated protein 1 with cell cycle regulator host cell factor 1. Mol Cell Biol 2009 29 2181 2192
13. Jensen DE, Proctor M, Marquis ST, BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 1998 16 1097 1112
14. Ventii KH, Devi NS, Friedrich KL, BRCA1-Associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res 2008 68 6953 6962
15. Scheuermann JC, de Ayala Alonso AG, Oktaba K, Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 2010 465 243 247
16. Machida YJ, Machida Y, Vashisht AA, Wohlschlegel JA, Dutta A, The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J Biol Chem 2009 284 34179 34188
17. Eletr ZM, Wilkinson KD, An emerging model for BAP1's role in regulating cell cycle progression. Cell Biochem Biophys 2011 60 3 11
18. Yu H, Mashtalir N, Daou S, The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol Cell Biol 2010 30 5071 5085
19. Ismail IH, Davidson R, Gagné JP, Xu ZZ, Poirier GG, Hendzel MJ, Germline mutations in BAP1 impair its function in DNA double-strand break repair. Cancer Res 2014 74 4282 4294
20. Yu H, Pak H, Hammond-Martel I, Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Proc Natl Acad Sci U S A 2014 111 285 290
21. Peña-Llopis S, Vega-Rubín-de-Celis S, Liao A, BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 2012 44 751 759
22. Harbour JW, Onken MD, Roberson ED, Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010 330 1410 1413
23. Bott M, Brevet M, Taylor BS, The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 2011 43 668 672
24. Zauderer MG, Bott M, McMillan R, Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations. J Thorac Oncol 2013 8 1430 1433
25. Arzt L, Quehenberger F, Halbwedl I, Mairinger T, Popper HH, BAP1 protein is a progression factor in malignant pleural mesothelioma. Pathol Oncol Res 2014 20 145 151
26. Yoshikawa Y, Sato A, Tsujimura T, Frequent inactivation of the BAP1 gene in epithelioid-Type malignant mesothelioma. Cancer Sci 2012 103 868 874
27. Cerutti R, Sahnane N, Carnevali I, Identification of the first case of germline duplication of BRCA1 exon 13 in an Italian family. Fam Cancer 2010 9 275 282
28. Yamada H, Shinmura K, Ito H, Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese population. Cancer Sci 2011 102 1782 1788
29. Yang X, Han H, De Carvalho DD, Lay FD, Jones PA, Liang G, Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell 2014 26 577 590
30. Abdel-Rahman MH, Pilarski R, Cebulla CM, Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 2011 48 856 859
31. Njauw CN, Kim I, Piris A, Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One 2012 7 e35295
32. Herman S, Varga D, Deissler HL, Kreienberg R, Deissler H, Medium-sized deletion in the BRCA1 gene: limitations of Sanger sequencing and MLPA analyses. Genet Mol Biol 2012 35 53 56
33. Hömig-Hölzel C, Savola S, Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics. Diagn Mol Pathol 2012 21 189 206
34. Gamazon ER, Stranger BE, Genomics of alternative splicing: evolution, development and pathophysiology. Hum Genet 2014 133 679 687
35. Adamia S, Haibe-Kains B, Pilarski PM, A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets. Clin Cancer Res 2014 20 1135 1145
36. Brandão RD, Tserpelis D, Gómez García E, Blok MJ, Detection of exon skipping events in BRCA1 RNA using MLPA kit P002. Mol Biol Rep 2012 39 7429 7433
37. Mashtalir N, Daou S, Barbour H, Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O. Mol Cell 2014 54 392 406
38. Gerlinger M, Rowan AJ, Horswell S, Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012 366 883 892
39. Comertpay S, Pastorino S, Tanji M, Evaluation of clonal origin of malignant mesothelioma. J Transl Med 2014 12 301
40. Vandermeers F, Neelature Sriramareddy S, Costa C, Hubaux R, Cosse JP, Willems L, The role of epigenetics in malignant pleural mesothelioma. Lung Cancer 2013 81 311 318
41. Christensen BC, Houseman EA, Godleski JJ, Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res 2009 69 227 234
42. Christensen BC, Godleski JJ, Marsit CJ, Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis 2008 29 1555 1559
43. Fischer JR, Ohnmacht U, Rieger N, Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma. Lung Cancer 2006 54 109 116
44. Amatori S, Papalini F, Lazzarini R, Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in malignant pleural mesothelioma (MPM) cells. Lung Cancer 2009 66 184 190
45. Ibragimova I, Maradeo ME, Dulaimi E, Cairns P, Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC. Epigenetics 2013 8 486 493
46. Hirao T, Bueno R, Chen CJ, Gordon GJ, Heilig E, Kelsey KT, Alterations of the p16(INK4) locus in human malignant mesothelial tumors. Carcinogenesis 2002 23 1127 1130
47. Ladanyi M, Zauderer MG, Krug LM, New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment. Clin Cancer Res 2012 18 4485 4490
48. Guo G, Chmielecki J, Goparaju C, Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Res 2015 75 264 269
49. Lo Iacono M, Monica V, Righi L, Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. J Thorac Oncol 2014. [Epub ahead of print